Buy & Sell ACADIA Pharmaceuticals Inc. (ACAD) – ACADIA Pharmaceuticals Inc. Price Today
Aura AI Summary
Key Stats
- $4.34BMarket Cap
- HealthSector
- -9.66%3M Drawdown
- $3.54BEnterprise Value
- -Dividend Yield
- 37% Buy | 63% SellTrading Activity
- 74 daysTypical Hold Time
ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $4.34B, with an enterprise value of $3.54B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -9.66%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 74 days, indicating typical investor behavior on the platform.
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Most Recent News
Supreme Court rules government geofence data collection is a Fourth Amendment search.
The U.S. Supreme Court ruled in Chatrie v. U.S. that government collection of location data via geofence warrants constitutes a search under the Fourth Amendment. This decision overturns a lower court ruling and requires further review of whether the...

Hub Group sued for securities fraud after misstating financials, stock drops sharply.
Hub Group, a transportation and logistics company, is facing a securities fraud lawsuit after admitting to misstating its financial reports from 2023 to 2025, including understating costs by about $77 million. The revelations caused the company's sto...

KraneShares China Internet ETF trades near lows amid AI growth and geopolitical risks, rated HOLD.
The KraneShares CSI China Internet ETF (KWEB) provides focused exposure to leading Chinese internet and AI companies and is currently trading near its 52-week lows. The ETF benefits from strong AI-driven growth, government support, and attractive val...
